Virbac: acquires Sasaeah in Japan

(CercleFinance.com) - Virbac announces the signature of a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of around E280m, a transaction which gives the French company a leading position in Japan.


Sasaeah develops, manufactures and markets a broad portfolio of veterinary products for livestock and companion animals. It generates annual revenues of around E75m, 50% of which come from vaccines, and has over 500 employees.

This transaction, which should be completed in early April, will give Virbac a leading position in farm animal vaccines in Japan, particularly for cattle, and a broad portfolio of pharmaceutical products for all the main species.


Copyright (c) 2024 CercleFinance.com. All rights reserved.